The new research partnership between PHARMAC and the HRC looks to answer questions that might not otherwise be asked, such as why don't some people get the full benefits of the medicines they take?
Biomedical research published by Wellington-based researcher Professor Mike Berridge and his colleague An Tan has achieved the equivalent of a gold medal in scientific circles – it has been cited,
The Australian and New Zealand Intensive Care Society Clinical Trials Group is estimated to have saved the New Zealand health care system well over $150 million per year over the past 10 years, and the lives of hundreds of New Zealanders.
It will take radical, fresh ideas and new technology to break some New Zealanders of their smoking habit and for smoking prevalence to be less than the Government’s goal of five per cent in New Zealand by 2025.
The Precision Driven Health Research Partnership is creating the capability to optimise the health of each individual and their whānau by combining and learning from all available data.
A world-first therapy for helping smokers quit that uses a nicotine-filled inhaler in combination with a nicotine patch has doubled quit rates compared to smokers using a nicotine patch only.
The government has today announced that the Health Research Council of New Zealand (HRC) will receive a significant new investment of $97 million over the next four years.